Grant ID PP200057
Awarded On August 19, 2020
Title School-based Human Papillomavirus Vaccination Program in the Rio Grande Valley: Continuation and Expansion in Starr, Zapata, and Jim Hogg County
Program Prevention
Award Mechanism Expansion of Cancer Prevention Services to Rural and Medically Underserved Populations
Institution/Organization The University of Texas Medical Branch at Galveston
Principal Investigator/Program Director Ana Rodriguez
Cancer Sites Cervix Uteri
Contracted Amount $1,993,140*

*Pending contract negotiation

Lay Summary

Need: The human papillomavirus (HPV) vaccine serves as an effective primary prevention strategy [1] by reducing morbidity and mortality of HPV-associated diseases (cervical, oropharyngeal, vulvar, vaginal, penile, anal cancer, anogenital warts) [2-10]. The overall annual direct medical cost of routine screening and treatment of HPV-associated disease is $8 billion (2010 USD). Direct costs could decrease if vaccination increased [11]. It is recommended for girls and boys aged 11-12, with catch-up doses for those aged 13-26 [8, 10]. US completion rates (49.5% for girls and 49.3% for boys aged 13-17 years) [12] are not reaching Healthy People 2020 goal of 80% of 13-15-year-olds fully vaccinated...

Read More